Medical

Trichuris suis

Also found in: Wikipedia.

Trichuris suis

a nematode species found in the pig; adult worms have been found in humans.
Farlex Partner Medical Dictionary © Farlex 2012

Tri·chu·ris su·is

(tri-kyūr'is sū'is)
A nematode species found in the pig; adult worms have been found in humans.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive
Indeed, extensively managed pigs are reported to harbor intestinal helminthes and protozoans [7] while pigs raised in intensive operations though thought to be less prone to gastrointestinal infestation are infested as well; the large roundworm (Ascaris suum), whipworm (Trichuris suis), the nodular worms (Oesophagostomum sp), and protozoa (Coccidia) are often found in intensive pig production [8, 9].
Sparks et al., "A genetic analysis of trichuris trichiura and trichuris suis from ecuador," Parasites Vectors, vol.
Trichuris suis (pig whipworm), for example, suppresses TLR4-induced inflammatory responses in human macrophages, according to M.
30 patients were given Trichuris suis eggs and 24 patients were given an oral placebo at 2 week intervals for 12 weeks.
El resto de bacterias y parasitos (Trichuris suis, Balantidium coli, Giardia intestinalis, Strongyloides spp., Metastrongylus spp., coccidias y "estrongilidos") por su impacto economico, su importancia epidemiologica y por ser potencialmente patogenas para otras especies, incluidos los humanos.
Washington, June 21 ( ANI ): A team consisting of 11 institutions from six countries, including BGI, presented the whole-genome sequence of Trichuris suis, a parasitic worm in pig.
Coronado Biosciences (CNDO), a US-based bioscences company, has started an investigator-initiated trial evaluating TSO (Trichuris suis ova or CNDO-201) for the treatment of paediatric patients with autism spectrum disorder (ASD), it was reported on Friday.
In fact, the Food and Drug Administration has granted pig whipworm (Trichuris suis) the status of Investigational New Drug.
The company's two principal pharmaceutical product candidates in clinical development are: TSO (Trichuris suis ova or CNDO-201), a biologic for the treatment of autoimmune diseases, such as Crohn's disease, ulcerative colitis and multiple sclerosis; and CNDO-109, a biologic that activates natural killer (NK) cells, for the treatment of acute myeloid leukemia (AML) and solid tumors.
Copyright © 2003-2025 Farlex, Inc Disclaimer
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.